Aldea, Mihaela

Tumour burden and efficacy of immune-checkpoint inhibitors

Dall’Olio, F. G., Marabelle, A., Caramella, C., Garcia, C., Aldea, M., Chaput, N., Robert, C., & Besse, B. (2022) · Nature Reviews Clinical Oncology

Cancer Immunotherapy and BiomarkersMedical Imaging Techniques and Applications

Cited by 350

Overcoming resistance to tumor-targeted and immune-targeted therapies

Aldea, M., Andre, F., Marabelle, A., Dogan, S., Barlesi, F., & Soria, J.-C. (2021) · Cancer Discovery

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations

Cited by 311

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Negrao, M. V., Araujo, H. A., Lamberti, G., Cooper, A. J., Akhave, N. S., Zhou, T., Delasos, L., Hicks, J. K., Aldea, M., Minuti, G., et al. (2023) · Cancer Discovery

Lung Cancer Treatments and MutationsCancer Genomics and Diagnostics

Cited by 203

ESMO guidance on the use of Large Language Models in Clinical Practice (ELCAP)

Wong, E. Y. T., Verlingue, L., Aldea, M., Franzoi, M. A., Umeton, R., Halabi, S., Harbeck, N., Indini, A., Prelaj, A., Romano, E., et al. (2025) · Annals of Oncology

Artificial Intelligence in Healthcare and EducationElectronic Health Records Systems

Cited by 44

End-To-End Clinical Trial Matching with Large Language Models

Ferber, D., Hilgers, L., Wiest, I. C., Leßmann, M.-E., Clusmann, J., Neidlinger, P., Zhu, J., Wölflein, G., Lammert, J., Tschochohei, M., et al. (2024) · arXiv

Artificial Intelligence in Healthcare and EducationMachine Learning in Healthcare

Cited by 12